Literature DB >> 12730739

The impact of a simple fracture clinic intervention in improving the diagnosis and treatment of osteoporosis in fragility fracture patients.

Gillian Hawker1, Rowena Ridout, Maria Ricupero, Susan Jaglal, Earl Bogoch.   

Abstract

We examined the effect of a fracture clinic intervention in reducing previously documented undertreatment of osteoporosis (OP) in individuals with fragility fractures. Fragility fracture patients presenting to five community fracture clinics with no prior diagnosis of, or treatment for OP, and whose radiographic appearance was consistent with fragility fracture, were included. These individuals (intervention group) were informed of their OP risk, and advised to follow up with their physician for assessment. A standardized letter, intended for the physician and outlining the same was provided. Three months later, a telephone interview determined whether a physician visit had occurred, and if so, what investigation and treatment recommendations were made. These outcomes were compared with those for an equal number of age- and sex-matched fragility fracture "controls," selected from among fracture clinic attendees in the 6-9 months preceding the intervention. Logistic regression was used to examine the effect of having received the intervention on physician follow-up, bone density testing, and OP treatment recommendations. The mean age of the 278 participants (139 per group) was 66.0 years; 74% were female. Adjusting for age, sex, hospital, and perceived diagnosis of OP, those who received the intervention were more likely to follow up with a physician (adjusted OR 1.85, p=0.02) and to be recommended bone density testing (adjusted OR 5.22, p<0.0001), but were not more likely to receive an OP treatment recommendation (adjusted OR 2.07, p=0.07). It is concluded that a simple fracture clinic intervention increased follow-up and investigation, but not treatment for OP, in fragility fracture patients. Individuals recommended treatment for OP were more likely to perceive themselves as having OP and to have had a previous fragility fracture. Our findings suggest that future interventions should incorporate assessment of patients' OP health beliefs and education about risk factors for fracture, and should be coupled with physician education to achieve optimal results.

Entities:  

Mesh:

Year:  2003        PMID: 12730739     DOI: 10.1007/s00198-003-1377-4

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  26 in total

1.  A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.

Authors:  C H Chesnut; S Silverman; K Andriano; H Genant; A Gimona; S Harris; D Kiel; M LeBoff; M Maricic; P Miller; C Moniz; M Peacock; P Richardson; N Watts; D Baylink
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

2.  How well are community-living women treated for osteoporosis after hip fracture?

Authors:  S Bellantonio; R Fortinsky; K Prestwood
Journal:  J Am Geriatr Soc       Date:  2001-09       Impact factor: 5.562

3.  Osteoporosis follow-up after wrist fractures following minor trauma.

Authors:  S A Khan; C de Geus; B Holroyd; A S Russell
Journal:  Arch Intern Med       Date:  2001-05-28

4.  Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group.

Authors:  H A Pols; D Felsenberg; D A Hanley; J Stepán; M Muñoz-Torres; T J Wilkin; G Qin-sheng; A M Galich; K Vandormael; A J Yates; B Stych
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

5.  Awareness of osteoporosis and compliance with management guidelines in patients with newly diagnosed low-impact fractures.

Authors:  H Castel; D Y Bonneh; M Sherf; Y Liel
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

6.  Alendronate for the treatment of osteoporosis in men.

Authors:  E Orwoll; M Ettinger; S Weiss; P Miller; D Kendler; J Graham; S Adami; K Weber; R Lorenc; P Pietschmann; K Vandormael; A Lombardi
Journal:  N Engl J Med       Date:  2000-08-31       Impact factor: 91.245

7.  Osteoporosis intervention following distal forearm fractures: a missed opportunity?

Authors:  Maria-Teresa Cuddihy; Sherine E Gabriel; Cynthia S Crowson; Elizabeth J Atkinson; Claudia Tabini; W Michael O'Fallon; L Joseph Melton
Journal:  Arch Intern Med       Date:  2002-02-25

8.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

Authors:  S T Harris; N B Watts; H K Genant; C D McKeever; T Hangartner; M Keller; C H Chesnut; J Brown; E F Eriksen; M S Hoseyni; D W Axelrod; P D Miller
Journal:  JAMA       Date:  1999-10-13       Impact factor: 56.272

9.  Medical costs of osteoporosis.

Authors:  R J Norris
Journal:  Bone       Date:  1992       Impact factor: 4.398

10.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

View more
  39 in total

1.  Secondary prevention program for osteoporotic fractures and long-term adherence to bisphosphonates.

Authors:  S Ojeda-Bruno; A Naranjo; F Francisco-Hernández; C Erausquin; I Rúa-Figueroa; J C Quevedo; C Rodríguez-Lozano
Journal:  Osteoporos Int       Date:  2010-10-06       Impact factor: 4.507

2.  The American Orthopaedic Association's Own the Bone® database: a national quality improvement project for the treatment of bone health in fragility fracture patients.

Authors:  B C Carlson; W A Robinson; N R Wanderman; A N Nassr; P M Huddleston; M J Yaszemski; B L Currier; K J Jeray; K L Kirk; A D Bunta; S Murphy; B Patel; C M Watkins; D L Sietsema; B J Edwards; L L Tosi; P A Anderson; B A Freedman
Journal:  Osteoporos Int       Date:  2018-06-01       Impact factor: 4.507

3.  Osteoporosis knowledge and information needs in healthcare professionals caring for patients with fragility fractures.

Authors:  L Giangregorio; Pauline Fisher; A Papaioannou; J D Adachi
Journal:  Orthop Nurs       Date:  2007 Jan-Feb       Impact factor: 0.913

4.  Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study.

Authors:  S R Majumdar; J A Johnson; D Bellerose; F A McAlister; A S Russell; D A Hanley; S Garg; D A Lier; W P Maksymowych; D W Morrish; B H Rowe
Journal:  Osteoporos Int       Date:  2010-04-01       Impact factor: 4.507

5.  A randomized study of two different information-based interventions on the management of osteoporosis in minimal and moderate trauma fractures.

Authors:  D Bliuc; J A Eisman; J R Center
Journal:  Osteoporos Int       Date:  2006-06-21       Impact factor: 4.507

Review 6.  Quality health care gaps in osteoporosis: how can patients, providers, and the health system do a better job?

Authors:  Gim Gee Teng; Jeffrey R Curtis; Kenneth G Saag
Journal:  Curr Osteoporos Rep       Date:  2009-03       Impact factor: 5.096

Review 7.  Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review.

Authors:  V Elliot-Gibson; E R Bogoch; S A Jamal; D E Beaton
Journal:  Osteoporos Int       Date:  2004-07-16       Impact factor: 4.507

8.  Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-11-01

9.  Community-based randomised controlled trial evaluating falls and osteoporosis risk management strategies.

Authors:  P M Ciaschini; S E Straus; L R Dolovich; R A Goeree; K M Leung; C R Woods; G M Zimmerman; S R Majumdar; S Spadafora; L A Fera; H N Lee
Journal:  Trials       Date:  2008-11-04       Impact factor: 2.279

10.  Brigham fracture intervention team initiatives for hospital patients with hip fractures: a paradigm shift.

Authors:  Julie Glowacki; Mitchel B Harris; Josef Simon; John Wright; Nikheel S Kolatkar; Thomas S Thornhill; Meryl S Leboff
Journal:  Int J Endocrinol       Date:  2010       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.